UPDATE 1-AstraZeneca looks beyond Nexium hit with new cancer deals

April 24, 2015 6:51 AM

2 0

* Drugmaker reiterates financial forecasts for year (Adds details on cancer drugs, background)

LONDON, April 24 (Reuters) - AstraZeneca has sharpened its focus on cancer drugs with two new deals as it looks beyond a hit to sales and profits from the launch of cheap copies of its popular stomach acid pill Nexium in the vital U.S. market.

Read more

To category page